Keiretsu Capital provides access to proprietary deal flow to its investors.
Keiretsu Capital provides access to proprietary deal flow to its investors. Keiretsu Capital works to increase the value of investments undertaken by Keiretsu Forum members by assisting in the successful presentation of the portfolio companies to investors including syndicate partners, venture capitalists, corporate investors, and the public markets.It aims to provide significant capital appreciation through investment in high quality emerging companies that have been funded by the world’s largest angel investor network, Keiretsu Forum, as well as other top tier angel groups.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 1, 2019 | Series Unknown | $3.60M | 1 | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 19, 2022
FEMSelect
|
Series B | $9M | Health Care | — |
Jun 29, 2018
Mission Bio
|
Series Unknown | — | Bioinformatics | — |
Dec 20, 2016
Phytelligence
|
Convertable Note | $3M | AgTech | — |
Jan 20, 2015
Kineta
|
Series B | $7M | Biotechnology | Yes |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Keiretsu Forum | — | Series Unknown |